Carregant...
Recent developments in biomarkers in Parkinson disease
PURPOSE OF REVIEW: Parkinson disease is the second most common neurodegenerative disease after Alzheimer disease, and current demographic trends indicate a life-time risk approaching 4% and predict a doubling of prevalence by 2030. Strategies are being developed to apply recent advances in our under...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4196782/ https://ncbi.nlm.nih.gov/pubmed/23823465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WCO.0b013e3283633741 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|